Phathom Pharmaceuticals, Inc.
PHAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$334,326 | -$201,592 | -$197,723 | -$143,883 |
| Dep. & Amort. | $795 | $575 | $620 | $521 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $24,047 | $45,025 | $0 | $16,812 |
| Change in WC | -$15,298 | -$13,644 | $5,438 | -$27,315 |
| Other Non-Cash | $58,012 | $32,056 | $45,135 | $5,408 |
| Operating Cash Flow | -$266,770 | -$137,580 | -$146,530 | -$148,457 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$135 | -$1,634 | -$1,041 | -$328 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$135 | -$1,634 | -$1,041 | -$328 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $59,400 | $39,318 | $95,446 | $42,764 |
| Stock Issued | $121,775 | $155,463 | $24,596 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,599 | $172,799 | $0 | $1,944 |
| Financing Cash Flow | $182,774 | $367,580 | $120,042 | $44,708 |
| Forex Effect | $0 | $0 | -$345 | $0 |
| Net Chg. in Cash | -$84,131 | $228,366 | -$27,874 | -$104,077 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $384,256 | $155,890 | $183,259 | $287,496 |
| End Cash | $300,125 | $384,256 | $155,385 | $183,419 |
| Free Cash Flow | -$266,905 | -$139,214 | -$147,571 | -$148,785 |